The schizophrenia prodrome: A developmentally informed review and update for psychopharmacologic treatment

Child and Adolescent Psychiatric Clinics of North America

Volumn 15, Issue 1, 2006, Pages 109-133

  Thomas, Lynelle E ^a,b   Woods, Scott W ^a,c  

^a PRIME Research Clinic   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; GLYCINE; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; OMEGA 3 FATTY ACID; PLACEBO; RISPERIDONE;

BEHAVIOR THERAPY; CHILD PSYCHIATRY; CLINICAL FEATURE; CLINICAL TRIAL; COGNITIVE THERAPY; DELUSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIAGNOSTIC VALUE; DISEASE COURSE; DRUG MECHANISM; DRUG TARGETING; GENETIC RISK; HALLUCINATION; HIGH RISK PATIENT; HUMAN; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; PSYCHOLOGIC ASSESSMENT; PSYCHOPHARMACOLOGY; RATING SCALE; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SCHIZOPHRENIA; SCHIZOTYPAL PERSONALITY DISORDER; SYMPTOMATOLOGY; TREATMENT OUTCOME; VALIDATION PROCESS;

ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; CHILD; CHILD, PRESCHOOL; HUMANS; SCHIZOPHRENIA; SEVERITY OF ILLNESS INDEX;

EID: 28444458806     PISSN: 10564993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chc.2005.08.011     Document Type: Review

References (103)

1. H.S. Sullivan The onset of schizophrenia Am J Psychiatry 7 1927 105 134
2. A.E. Simon, F.P. Ferrero, and M.C.G. Merlo Prodromes of first-episode psychosis: how can we challenge nonspecificity? Compr Psychiatry 42 5 2001 382 392
3. B. Fish, J. Marcus, and S.L. Hans Infants at risk for schizophrenia: sequelae of a genetic neurointegrative defect. A review and replication analysis of pandysmaturation in the Jerusalem Infant Development Study Arch Gen Psychiatry 49 1992 221 235
4. J. McClellan, and C. McCurry Early onset psychotic disorders: diagnostic stability and clinical characteristics Eur Child Adolesc Psychiatry 8 Suppl 1 1999 13 19
5. A.R. Yung, and P.D. McGorry The prodromal phase of first-episode psychosis: past and current conceptualizations Schizophr Bull 22 2 1996 353 370
6. S.W. Woods, T.J. Miller, and T.H. McGlashan The prodromal patient: both symptomatic and at risk CNS Spectr 6 2001 223 232
7. R. McGee, S. Williams, and R. Poulton Hallucinations in nonpsychotic children J Am Acad Child Adolesc Psychiatry 39 1 2000 12 13
8. H. Hafner, K. Maurer, and W. Loffler The influence of age and sex on the onset and early course of schizophrenia Br J Psychiatry 162 1993 80 86
9. M. Cannon, C.J. Tarrant, and M.O. Huttenen Childhood development and later schizophrenia: evidence from genetic high-risk and birth cohort studies R.M. Murray P.B. Jones E. Susser The epidemiology of schizophrenia 2003 Cambridge University Press Cambridge (UK) 100 123
10. P. Jones, B. Rodgers, and R. Murray Child developmental risk-factors for adult schizophrenia in the British 1946 birth cohort Lancet 344 8934 1994 1398 1402
11. T.J. Crow, D.J. Done, and A. Sacker Childhood precursors of psychosis as clues to its evolutionary origins Eur Arch Psychiatry Clin Neurosci 245 2 1995 61 69
12. M. Isohanni, P.B. Jones, and K. Moilanen Early developmental milestones in adult schizophrenia and other psychoses. A 31-year follow-up of the northern Finland 1966 birth cohort Schizophr Res 52 1-2 2001 1 19
13. M. Isohanni, G.K. Murray, and J. Jokelainen The persistence of developmental markers in childhood and adolescence and risk for schizophrenic psychoses in adult life. A 34-year follow-up of the northern Finland 1966 birth cohort Schizophr Res 71 2-3 2004 213 225
14. I.M. Rosso, C.E. Bearden, and J.M. Hollister Childhood neuromotor dysfunction in schizophrenia patients and their unaffected siblings: a prospective cohort study Schizophr Bull 26 2 2000 367 378
15. R. Poulton, A. Caspi, and T.E. Moffitt Children's self-reported psychotic symptoms and adult schizophreniform disorder: a 15-year longitudinal study Arch Gen Psychiatry 57 11 2000 1053 1058
16. M. Cannon, A. Caspi, and T.E. Moffitt Evidence for early-childhood pan-developmental impairment specific to schizophreniform disorder: results from a longitudinal birth cohort Arch Gen Psychiatry 59 5 2002 449 457
17. B. Fish Neurobiologic antecedents of schizophrenia in children. Evidence for an inherited, congenital neurointegrative defect Arch Gen Psychiatry 34 11 1977 1297 1313
18. S.L. Hans, J.G. Auerbach, and B. Styr Offspring of parents with schizophrenia: mental disorders during childhood and adolescence Schizophr Bull 30 2 2004 303 315
19. S.A. Mednick, J. Parnas, and F. Schulsinger The Copenhagen high-risk project, 1962-86 Schizophr Bull 13 3 1987 485 495
20. L. Erlenmeyer-Kimling, D. Rock, and S.A. Roberts Attention, memory, and motor skills as childhood predictors of schizophrenia-related psychoses: The New York high-risk project Am J Psychiatry 157 9 2000 1416 1422
21. A.F. Mirsky, S. Kugelmass, and L.J. Ingraham Overview and summary: twenty-five-year followup of high-risk children Schizophr Bull 21 2 1995 227 239
22. S.A. Mednick, J. Parnas, and F. Schulsinger The Copenhagen high-risk project, 1962-86 Schizophr Bull 13 3 1987 485 495
23. P. Tienari Interaction between genetic vulnerability and family environment: the Finnish adoptive family study of schizophrenia Acta Psychiatr Scand 84 5 1991 460 465
24. M. Metsanen, K.E. Wahlberg, and O. Saarento Early presence of thought disorder as a prospective sign of mental disorder Psychiatry Res 125 3 2004 193 203
25. E.C. Johnstone, K.P. Ebmeier, and P. Miller Predicting schizophrenia: findings from the Edinburgh high-risk study Br J Psychiatry 186 2005 18 25
26. Owens D.G.C., Miller P., Lawrie S.M., Jet al. Pathogenesis of schizophrenia: a psychopathological perspective. Br J Psychiatry 2005;186:386-93
27. M. Davidson, A. Reichenberg, and J. Rabinowitz Behavioral and intellectual markers for schizophrenia in apparently healthy male adolescents Am J Psychiatry 156 9 1999 1328 1335
28. S. Zammit, P. Allebeck, and A.S. David A longitudinal study of premorbid iq score and risk of developing schizophrenia, bipolar disorder, severe depression, and other nonaffective psychoses Arch Gen Psychiatry 61 4 2004 354 360
29. G. Lewis, A.S. David, and A. Malmberg Non-psychotic psychiatric disorder and subsequent risk of schizophrenia. Cohort study Br J Psychiatry 177 2000 416 420
30. R. Fuller, P. Nopoulos, and S. Arndt Longitudinal assessment of premorbid cognitive functioning in patients with schizophrenia through examination of standardized scholastic test performance Am J Psychiatry 159 7 2002 1183 1189
31. M. Cannon, P. Jones, and M.O. Huttunen School performance in Finnish children and later development of schizophrenia-a population-based longitudinal study Arch Gen Psychiatry 56 5 1999 457 463
32. M. Cannon, E. Walsh, and C. Hollis Predictors of later schizophrenia and affective psychosis among attendees at a child psychiatry department Br J Psychiatry 178 2001 420 426
33. E. Walker, and R.J. Lewine Prediction of adult-onset schizophrenia from childhood home movies of the patients Am J Psychiatry 147 8 1990 1052 1056
34. J. Schiffman, E. Walker, and M. Ekstrom Childhood videotaped social and neuromotor precursors of schizophrenia: a prospective investigation Am J Psychiatry 161 11 2004 2021 2027
35. P.D. McGorry, C. McFarlane, and G.C. Patton The prevalence of prodromal features of schizophrenia in adolescence: a preliminary survey Acta Psychiatr Scand 92 4 1995 241 249
36. A.R. Yung, and P.D. McGorry The prodromal phase of first-episode psychosis: past and current conceptualizations Schizophr Bull 22 2 1996 353 370
37. A.R. Yung, L.J. Phillips, and P.D. McGorry Prediction of psychosis. A step towards indicated prevention of schizophrenia Br J Psychiatry 172 33 Suppl 1998 14 20
38. K.F. Schaffner, and P.D. McGorry Preventing severe mental illnesses-new prospects and ethical challenges Schizophr Res 51 1 Special Issue SI 2001 3 15
39. T.J. Miller, T.M. McGlashan, and J.L. Rosen Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, inter-rater reliability, and training to reliability Schizophr Bull 29 4 2003 703 715
40. T.J. Miller, T.H. McGlashan, and J.L. Rosen Prospective diagnosis of the prodrome for schizophrenia: preliminary evidence of interrater reliability and predictive validity using operational criteria and a structured interview Am J Psychiatry 159 2002 863 865
41. A.R. Yung, L.J. Phillips, and H.P. Yuen Risk factors for psychosis in an ultra high-risk group: psychopathology and clinical features Schizophr Res 67 2-3 2004 131 142
42. O. Mason, M. Startup, and S. Halpin Risk factors for transition to first episode psychosis among individuals with 'at-risk mental states' Schizophr Res 71 2-3 2004 227 237
43. T.J. Miller, R.B. Zipursky, and D.O. Perkins A randomized double blind clinical trial of olanzapine vs placebo in patients at risk for being prodromally symptomatic for psychosis: II. Baseline characteristics of the "prodromal" sample Schizophr Res 61 1 2003 19 30
44. P.D. McGorry, A.F. Yung, and L.J. Phillips Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms Arch Gen Psychiatry 59 2002 921 928
45. A.R. Yung, L.J. Phillips, and H.P. Yuen Psychosis prediction: 12-month follow up of a high-risk ("prodromal") group Schizophr Res 60 1 2003 21 32
46. J.L. Rosen, T.J. Miller, and J.T. D'Andrea Comorbid diagnoses in persons meeting criteria for the schizophrenic prodrome [abstract] Schizophr Res 67 1 Suppl 1 2004 73
47. T.H. McGlashan, R.B. Zipursky, and D.O. Perkins Olanzapine vs placebo for prodromal schizophrenia Schizophr Res 67 1 Suppl 1 2004 6
48. A.P. Morrison, P. French, and L. Walford Cognitive therapy for the prevention of psychosis in people at ultra-high risk. Randomized controlled trial Br J Psychiatry 184 2004 291 297
49. T.H. McGlashan, T.J. Miller, and S.W. Woods Pre-onset detection and intervention research in schizophrenic psychoses; current estimates of benefits and risks Schizophr Bull 27 2001 563 570
50. A.R. Yung, P.D. McGorry, and C.A. McFarlane Monitoring and care of young people at incipient risk of psychosis Schizophr Bull 22 2 1996 283 303
51. P. Moller, and R. Husby The initial prodrome in schizophrenia: searching for naturalistic core dimensions of experience and behavior Schizophr Bull 26 1 2000 217 232
52. T.J. Miller, and T.M. McGlashan Early identification and intervention in psychotic illness Conn Med 64 6 2000 339 341
53. A. Preda, T.J. Miller, and J.L. Rosen Treatment histories of patients with a syndrome putatively prodromal for schizophrenia Psychiatr Serv 53 3 2002 342 344
54. K.A. Hawkins, J. Addington, and R.S.E. Keefe Neuropsychological status of subjects at high risk for a first episode of psychosis Schizophr Res 67 2004 115 122
55. Institute of Medicine (IOM) Research on children and adolescents with mental, behavioral and developmental disorders 1989 National Academy Press Washington (DC)
56. I.R.H. Falloon Early intervention for first episodes of schizophrenia: a preliminary exploration Psychiatry 55 1992 4 15
57. P.D. McGorry, and R. Warner Consensus on early intervention in schizophrenia Schizophr Bull 28 3 2002 543 544
58. S.W. Woods, A. Breier, and R.B. Zipursky Randomized trial of olanzapine vs placebo in the symptomatic acute treatment of patients meeting criteria for the schizophrenic prodrome Biol Psychiatry 54 2003 453 464
59. W.T. Carpenter Jr, P.S. Appelbaum, and R.J. Levine The declaration of Helsinki and clinical trials: a focus on placebo-controlled trials in schizophrenia Am J Psychiatry 160 2 2003 356 362
60. S.W. Woods Chlorpromazine equivalent doses for the newer atypical antipsychotics J Clin Psychiatry 64 2003 663 667
61. S.W. Woods, A. Martin, and S.G. Spector Effects of development on olanzapine-associated adverse events J Am Acad Child Adolesc Psychiatry 41 2002 1439 1446
62. J.W. Olney, and N.B. Farber Glutamate receptor dysfunction and schizophrenia Arch Gen Psychiatry 52 12 1995 998 1007
63. J.M. Kane, J. Krystal, and C.U. Correll Treatment models and designs for intervention research during the psychotic prodrome Schizophr Bull 29 4 2003 747 756
64. D.C. Javitt, A. Balla, and H. Sershen A.E. Bennett Research Award. Reversal of phencyclidine-induced effects by glycine and glycine transport inhibitors Biol Psychiatry 45 6 1999 668 679
65. W.Y. Lu, H.Y. Man, and W. Ju Activation of synaptic NMDA receptors induces membrane insertion of new AMPA receptors and LTP in cultured hippocampal neurons Neuron 29 1 2001 243 254
66. U. Heresco-Levy, M. Ermilov, and P. Lichtenberg High-dose glycine added to olanzapine and risperidone for the treatment of schizophrenia Biol Psychiatry 55 2 2004 165 171
67. S.W. Woods, L.E. Thomas, and E.M. Tully Effects of oral glycine in the schizophrenia prodrome [abstract] Biol Psychiatry 55 8S 2004 227
68. S.W. Woods, R.V. Gueorguieva, and C.B. Baker Control group bias in randomized atypical antipsychotic trials for schizophrenia Arch Gen Psychiatry 62 9 2005 961 970
69. J.M. Azorin, and J. Naudin Schizophrenia: two-faced meaning of vulnerability Am J Med Genet 114 8 2002 921 922
70. J.M. Fiszdon, G.J. Bryson, and B.E. Wexler Durability of cognitive remediation training in schizophrenia: performance on two memory tasks at 6-month and 12-month follow-up Psychiatry Res 125 1 2004 1 7
71. A.F. Lehman, J.A. Lieberman, and L.B. Dixon Practice guideline for the treatment of patients with schizophrenia, second edition Am J Psychiatry 161 2 Suppl S 2004 1 56
72. J. McClellan, J.S. Werry, and W. Ayres Practice parameters for the assessment and treatment of children and adolescents with schizophrenia J Am Acad Child Adolesc Psychiatry 36 10 Suppl S 1997 S177 S193
73. M. Davidson, and M. Weiser Prodromal schizophrenia: the dilemma of prediction and early intervention CNS Spectr 9 6 2004 578
74. S.W. Woods, A. Martin, and S.G. Spector Effects of development on olanzapine-associated adverse events J Am Acad Child Adolesc Psychiatry 41 2002 1439 1446
75. B. Fish, and E. Ritvo Psychosis of childhood J.D. Noshpitz Basic handbook of child psychiatry 1979 Basic Books New York 249 304
76. A.F. Clark, and S.W. Lewis Practitioner review: treatment of schizophrenia in childhood and adolescence J Child Psychol Psychiatry 39 8 1998 1071 1081
77. J.R. Asarnow, M.C. Tompson, and E.P. McGrath Annotation: childhood-schizophrenia: clinical and treatment issues J Child Psychol Psychiatr 45 2004 180 194
78. Schizophrenia. Biological markers in relations to clinical characteristics Am J Psychiatry 154 1997 64 68
79. K. Hata, J. Iida, and H. Iwasaka Minor physical anomalies in childhood and adolescent onset schizophrenia Psychiatry Clin Neurosci 57 2003 17 21
80. S.C. Schultz, R.L. Findlng, and A. Wise Schizophrenia-child and adolescent schizophrenia Psychiatr Clin North Am 21 1998 43 56
81. J. Alaghband-Rad, M.A. Hamburger, and J.N. Giedd Childhood-onset schizophrenia: biological markers in relations to clinical characteristics Am J Psychiatry 154 1997 64 68
82. American Psychiatric Association Diagnostic and statistical manual of mental disorders 3rd edition 1980 American Psychiatric Association Washington (DC)
83. F.R. Volkmar, and K.D. Tsatsanis Childhood schizophrenia M. Lewis Child and adolescent psychiatry-a comprehensive textbook 3rd edition 2002 Lippincott Williams and Wilkins Philadephia 745 754
84. J.H. Beitchman Childhood schizophrenia: a review and comparison of adult onset schizophrenia Psychiatr Clin North Am 8 1985 793 814
85. R.F. Asarnow, and J.R. Asarnow Childhood-onset schizophrenia Schizophr Bull 20 1994 591 597
86. E.K. Spencer, and M. Campbell Children with schizophrenia: diagnosis, phenomenology, and pharmacotherapy Schizophr Bull 20 1994 713 725
87. A. Aleman, R.S. Kahn, and J.-P. Selten Sex differences in the risk of schizophrenia. Evidence from meta-analysis Arch Gen Psychiatry 60 6 2003 565 571
88. D. Castle, P. Sham, and R. Murray Differences in distribution of ages of onset in males and females with schizophrenia Schizophr Res 33 3 1998 179 183
89. H. Hafner, W. an der Heiden, and S. Behrens Causes and consequences of the gender difference in age at onset of schizophrenia Schizophr Bull 24 1 1998 99 113
90. J.A. Frazier, J. Alaghband-Rad, and L. Jacobsen Pubertal development and onset of psychosis in childhood onset schizophrenia Psychiatry Res 70 1997 1 7
91. R.Z. Cohen, M.V. Seeman, and A. Gotowiec Earlier puberty as a predictor of later onset of schizophrenia in women Am J Psychiatry 156 7 1999 1059 1064
92. G. Wyshak, and R.E. Frisch Evidence for a secular trend in age of menarche N Engl J Med 306 17 1982 1033 1035
93. B. Hulanicka, and A. Waliszko Deceleration of age at menarche in Poland Ann Hum Biol 18 6 1991 507 513
94. P.A. Lee, S.S. Guo, and H.E. Kulin Age of puberty: data from the United States of America APMIS 109 2 2001 81 88
95. R. Caplan, D. Guthrie, and P. Tanguay Formal thought disorder in childhood onset schizophrenia and schizotypal personality disorder J Child Psychol Psychiatr 31 1990 1103 1114
96. American Psychiatric Association Diagnostic and statistical manual of mental disorders 4th edition 1994 American Psychiatric Association Washington (DC)
97. R. McGee, S. Williams, and R. Poulton Hallucinations in nonpsychotic children J Am Acad Child Adolesc Psychiatry 39 1 2000 12 13
98. S. Escher, M. Romme, and A. Buiks Formation of delusional ideation in adolescent hearing voices: a prospective study Am J Med Genet 114 2002 913 920
99. S. Kumra, L.K. Jacobsen, and M. Lenane Multidimensionally impaired disorder-is it a variant of very early-onset schizophrenia J Am Acad Child Adolesc Psychiatry 37 1 1998 91 99
100. R.G. Ross, J. Schaeffer, and N. Compagnon Creating school-age versions of semistructured interviews for the prodrome to schizophrenia: lessons from case reviews Schizophr Bull 29 4 2003 729 735
101. N. Schooler, J. Rabinowitz, and M. Davidson Risperidone and haloperidol in first-episode psychosis: a long-term randomized trial Am J Psychiatry 162 5 2005 947 953
102. J.A. Lieberman, G. Tollefson, and M. Tohen Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: a randomized, double-blind trial of olanzapine versus haloperidol Am J Psychiatry 160 8 2003 1396 1404
103. L. Sikich, R.M. Hamer, and R.A. Bashford A pilot study of risperidone, olanzapine, and haloperidol in psychotic youth: a double-blind, randomized, 8-week trial Neuropsychopharmacology 29 1 2004 133 145